Viewing Study NCT05345327


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-05-05 @ 1:35 PM
Study NCT ID: NCT05345327
Status: RECRUITING
Last Update Posted: 2024-12-20
First Post: 2022-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Sponsor:
Organization: